A detailed history of Principal Securities, Inc. transactions in Vericel Corp stock. As of the latest transaction made, Principal Securities, Inc. holds 225 shares of VCEL stock, worth $12,759. This represents 0.0% of its overall portfolio holdings.

Number of Shares
225
Previous 223 0.9%
Holding current value
$12,759
Previous $10.2 Million 7.09%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$42.25 - $53.56 $84 - $107
2 Added 0.9%
225 $9.51 Million
Q1 2024

May 10, 2024

BUY
$32.52 - $52.33 $2,959 - $4,762
91 Added 68.94%
223 $11.6 Million
Q4 2023

Feb 07, 2024

BUY
$30.85 - $37.09 $4,072 - $4,895
132 New
132 $4.7 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.68B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.